92 related articles for article (PubMed ID: 2688231)
21. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
Baldini G; Gucci M; Tarò D; Memmini C
Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
[TBL] [Abstract][Full Text] [Related]
22. [N-acetylcystein in the therapy of chronic bronchitis].
Reichenberger F; Tamm M
Pneumologie; 2002 Dec; 56(12):793-7. PubMed ID: 12486618
[TBL] [Abstract][Full Text] [Related]
23. High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial.
Johnson K; McEvoy CE; Naqvi S; Wendt C; Reilkoff RA; Kunisaki KM; Wetherbee EE; Nelson D; Tirouvanziam R; Niewoehner DE
Int J Chron Obstruct Pulmon Dis; 2016; 11():799-807. PubMed ID: 27143871
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the bronchodilatory action and side-effects of ipratropium bromide and thiazinamium methyl sulphate: a long-term, double-blind, crossover trial in patients with chronic bronchitis.
Verheijen-Breemhaar L; Bogaard JM; Hilvering C
Pharmatherapeutica; 1982; 3(3):180-7. PubMed ID: 6127719
[TBL] [Abstract][Full Text] [Related]
25. Effects of corticosteroids in "chronic bronchitis" and "chronic obstructive airway disease".
Postma DS; Renkema TE; Koëter GH
Agents Actions Suppl; 1990; 30():41-57. PubMed ID: 2239541
[TBL] [Abstract][Full Text] [Related]
26. Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol.
Ashutosh K; Lang H
Ann Allergy; 1984 Nov; 53(5):401-6. PubMed ID: 6238558
[TBL] [Abstract][Full Text] [Related]
27. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
Adabag AS; Ishani A; Koneswaran S; Johnson DJ; Kelly RF; Ward HB; McFalls EO; Bloomfield HE; Chandrashekhar Y
Am Heart J; 2008 Jun; 155(6):1143-9. PubMed ID: 18513531
[TBL] [Abstract][Full Text] [Related]
28. [Therapy of respiratory tract diseases with N-acetylcysteine. An open therapeutic observation study of 2,512 patients].
Völkl KP; Schneider B
Fortschr Med; 1992 Jun; 110(18):346-50. PubMed ID: 1644396
[TBL] [Abstract][Full Text] [Related]
29. Long-term home use of acetylcysteine in chronic bronchitis.
Chodosh S; Baigelman W; Medici TC; Enslein K
Curr Ther Res Clin Exp; 1975 Apr; 17(4):319-34. PubMed ID: 804379
[No Abstract] [Full Text] [Related]
30. Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis.
Hansen NC; Skriver A; Brorsen-Riis L; Balsløv S; Evald T; Maltbaek N; Gunnersen G; Garsdal P; Sander P; Pedersen JZ
Respir Med; 1994 Aug; 88(7):531-5. PubMed ID: 7972979
[TBL] [Abstract][Full Text] [Related]
31. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo.
Verstraeten JM
Acta Tuberc Pneumol Belg; 1979; 70(1):71-80. PubMed ID: 398153
[No Abstract] [Full Text] [Related]
32. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review.
Stey C; Steurer J; Bachmann S; Medici TC; Tramèr MR
Eur Respir J; 2000 Aug; 16(2):253-62. PubMed ID: 10968500
[TBL] [Abstract][Full Text] [Related]
33. [The effect of rehabilitation procedures on pulmonary function in patients with chronic obstructive bronchitis].
Popović G; Djurković-Ivanović S
Srp Arh Celok Lek; 1991; 119(5-6):134-7. PubMed ID: 1792563
[TBL] [Abstract][Full Text] [Related]
34. [Therapy of bronchitis. Successful single-dosage treatment with N-acetylcysteine, results of an administration surveillance study in 3,076 patients].
Gerards HH; Vits U
Fortschr Med; 1991 Nov; 109(34):707-10. PubMed ID: 1765342
[TBL] [Abstract][Full Text] [Related]
35. A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis.
Grassi C; Morandini GC
Eur J Clin Pharmacol; 1976 Mar; 09(5-6):393-6. PubMed ID: 786665
[TBL] [Abstract][Full Text] [Related]
36. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee.
Thorax; 1985 Nov; 40(11):832-5. PubMed ID: 2866607
[TBL] [Abstract][Full Text] [Related]
37. N-isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis.
Ekberg-Jansson A; Larson M; MacNee W; Tunek A; Wahlgren L; Wouters EF; Larsson S
Eur Respir J; 1999 Apr; 13(4):829-34. PubMed ID: 10362048
[TBL] [Abstract][Full Text] [Related]
38. No effect of oral N-acetylcysteine on the bioavailability of erythromycin and bacampicillin.
Paulsen O; Borgström L; Kågedal B; Walder M
Eur Respir J; 1988 Feb; 1(2):171-5. PubMed ID: 3360092
[TBL] [Abstract][Full Text] [Related]
39. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?
Riise GC; Larsson S; Larsson P; Jeansson S; Andersson BA
Eur Respir J; 1994 Jan; 7(1):94-101. PubMed ID: 8143838
[TBL] [Abstract][Full Text] [Related]
40. [Double blind study of the effect of alveolar air distribution influenced by RG 033 in chronic bronchitis].
Dal Negro R; Dal Negro-Turco P; Lorenzi E; Serra R; Minette A
Rev Inst Hyg Mines (Hasselt); 1979; 34(3):134-40. PubMed ID: 552658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
